Rhode Island Physician Ebook Continuing Education

Frontotemporal Dementia _____________________________________________________________________

F inal E xam

FRONTOTEMPORAL DEMENTIA

Select the best answer for each question and mark your answers on the Final Examination Answer Sheet found on page 91, or complete your test online at BOOK.CME.EDU. A passing grade of at least 70% must be achieved in order to receive credit for this course.

41. The age of onset for frontotemporal dementia (FTD) is typically

46. Which of the following best describes the differences between the early symptoms of FTD and Alzheimer disease (AD)? A) Age of onset is generally earlier in AD than FTD. B) Memory decline is generally the first symptom of AD, whereas behavior, language, and/or movement decline are generally the first symptoms of FTD. C) Problems with gait, balance, rigidity, apraxia, or muscle weakness occur frequently in early AD, whereas movement problems are rare in early FTD. D) Language problems in FTD involve word-finding,

A) 20 to 30 years. B) 30 to 45 years. C) 45 to 64 years. D) 65 years or older.

42. Which areas of the brain are typically atrophied in patients with FTD?

A) Substantia nigra and pons B) Occipital and parietal lobes C) Hippocampus and thalamus D) Frontal and anterior temporal lobes

whereas language problems in AD involve speech production, understanding word meaning, and recognizing familiar objects.

43. The most common presentation of FTD is A) behavioral variant FTD. B) corticobasal degeneration.

47. If a parent carries a genetic mutation in the MAPT gene causing FTD, what is the risk to his/her child of inheriting the same genetic mutation? A) Less than 1%

C) semantic variant primary progressive aphasia. D) logopenic variant primary progressive aphasia.

B) 25% C) 50% D) More than 99%

44. Which of the following personality traits or behaviors is typically seen with behavioral variant FTD (bvFTD)? A) Empathy

48. Which of the following medications has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of FTD? A) Donepezil B) Trazadone C) Olanzapine D) No medication has been approved by the FDA for the treatment of FTD.

B) Sociability C) Inhibitions D) Compulsive behaviors

45. A person diagnosed with nonfluent/agrammatic variant primary progressive aphasia would have difficulty A) producing speech.

B) recognizing a familiar face. C) remembering the correct word. D) understanding the meaning of a word.

Self-Assessment questions continue on next page 

61

MDRI2026

Powered by